Losartan titration versus diuretic combination in type 2 diabetic patients

被引:9
|
作者
de Pablos-Velasco, PL
Toral, FP
Esmatjes, JE
Fernandez-Vega, F
de la Torre, ML
Pozuelo, A
Ruilope, LM
机构
[1] Hosp 12 Octubre, Unidad Hipertens, E-28041 Madrid, Spain
[2] H Gen Gran Canaria Dr Negrin, Las Palmas Gran Canaria, Spain
[3] H Marques Valdecilla, Santander, Spain
[4] Hosp Clin Barcelona, Barcelona, Spain
[5] Hosp Cent Asturias, Oviedo, Spain
[6] Hosp Virgen Nieves, Granada, Spain
关键词
type; 2; diabetes; arterial hypertension; losartan; microalbuminuria; angiotensin receptor antagonists;
D O I
10.1097/00004872-200204000-00030
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Methods We compared the effects of Losartan dose titration to 100 mg versus the addition of 12.5 mg of hydrochlorothiazide, in 90 type 2 diabetic patients with microalbuminuria and blood pressure > 130/85 mmHg, receiving losartan 50 mg as initial treatment during 4 weeks. Results With the first dose of losartan, systolic (SBP) and diastolic blood pressure (DBP) decreased from 154.5 (152.1 -157.5) to 144.4 (141.3-147.5) mmHg (P < 0.001) and from 91.1 (89.4-92.8) to 84.6 (82.8-86.4) mmHg (P < 0.001), with 20 patients attaining the expected goal blood pressure (< 130/85 mmHg); albuminuria decreased from 109.8 (90.5-133.3) to 83.5 (63.6-109.5) mg per 24 h (P = 0.006). Patients not attaining the target blood pressure were randomly allocated to titration or to the combination arm. After an additional 4 weeks, patients titrated exhibited a fall in SBP and DBP from 157.1 (152.7-161.5) to 142.1 (136.4-147.8) mmHg (P < 0.001) and from 92.4 (89.5-95.3) to 83.6 (81.1-86.1) mmHg (P < 0.001); albuminuria decreased from 136.3 (97.8-189.9) to 99.7 (69.3-143.4) mg per 24 h (P = 0.002). In the combination arm, there were similar reductions in SBP and DBP from 155.3 (151.5-159.1) to 139.1 (132.1-146.1) mmHg (P < 0.001) and from 92.1 (89.3-94.9) to 80.9 (77.4-84.4) mmHg (P < 0.001); while albuminuria fell from 107.7 (82.2-141.0) to 64.2 (45.9-89.9) mg per 24 h (P = 0.001). Conclusions Losartan 50 mg was effective in reducing blood pressure and albuminuria in type 2 diabetic patients. When the blood pressure target was not reached, the two strategies tested seem to contribute similarly to further reductions in blood pressure and albuminuria. J Hypertens 20:715-719 (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:715 / 719
页数:5
相关论文
共 50 条
  • [31] Apolipoprotein H is increased in type 2 diabetic patients with microalbuminuria
    Perin, PC
    Gruden, G
    Giunti, S
    Arnaldi, L
    Cassader, M
    Gambino, R
    Pagano, G
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2000, 10 (06) : 311 - 314
  • [32] Antihypertensive Drugs and Diabetic Retinopathy in Patients with Type 2 Diabetes
    Lin, Jen-Chieh
    Lai, Mei-Shu
    OPHTHALMOLOGICA, 2016, 235 (02) : 87 - 96
  • [33] Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics
    Lozano, JV
    Llisterri, JL
    Aznar, J
    Redon, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 85 - 89
  • [34] Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study
    Ji, Li-Nong
    Pan, Chang-Yu
    Lu, Ju-Ming
    Li, Hong
    Li, Qiang
    Li, Qi-Fu
    Peng, Yong-De
    Tian, Hao-Ming
    Yao, Chen
    Zhao, Zhi-Gang
    Zhang, Ru-Ya
    Wang, Xiang-Ling
    Wang, Lei
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [35] Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetic patients
    Lim, Su Chi
    Liu, Jian-Jun
    Subramaniam, Tavintharan
    Sum, Chee Fang
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2014, 15 (04) : 487 - 490
  • [36] Risk factors of diabetic retinopathy in type 2 diabetic patients
    CAI Xiao-ling
    中华医学杂志(英文版), 2006, (10) : 822 - 826
  • [37] Review of the AMADEO Study: Reducing Proteinuria in Patients with Diabetic Nephropathy with Telmisartan Versus Losartan
    Toth, Peter P.
    POSTGRADUATE MEDICINE, 2010, 122 (02) : 165 - 168
  • [38] The effect of dual PPAR α/γ stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients
    Seber, S
    Ucak, S
    Basat, O
    Altuntas, Y
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 71 (01) : 52 - 58
  • [39] Effects of a low-dose antihypertensive diuretic in combination with losartan, telmisartan, or candesartan on serum urate levels in hypertensive patients
    Hamada, Toshihiro
    Mizuta, Einosuke
    Kondo, Takehito
    Hirai, Masayuki
    Yamada, Kensaku
    Kato, Masahiko
    Shigemasa, Chiaki
    Yamamoto, Yasutaka
    Ninomiya, Haruaki
    Igawa, Osamu
    Hisatome, Ichiro
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2010, 60 (02): : 71 - 75
  • [40] Risk factors of diabetic retinopathy in type 2 diabetic patients
    Cai Xiao-ling
    Wang Fang
    Ji Li-nong
    CHINESE MEDICAL JOURNAL, 2006, 119 (10) : 822 - 826